menu search

Dyadic to present at industry and investor events in october

JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo...

September 29, 2023, 8:30 am

Zinc oxide nanoparticles market to be worth us$ 738.0 million by 2033: fact.mr report

Climbing Penetration of Zinc Oxide nanoparticles in Personal Care Industry to Enhance Sales Rockville, ...

May 12, 2023, 3:00 pm

Silver nanoparticles market: 2023 focus on latest opportunities and growing demand, revenue analysis and forecast to 2027

Jan 25, 2023 (The Expresswire) — “Silver nanoparticles Market” Size Outlook with a bottom-up anal...

January 28, 2023, 7:29 am

Gold nanoparticles market size 2023 with new report by prominent players & peak selling price till 2027

Jan 15, 2023 (The Expresswire) — “Gold nanoparticles Market” New Research Insights Report 2023 | ...

January 15, 2023, 11:44 pm

Genprex says preclinical data shows potential for oncoprex nanoparticle delivery system in treating colon cancer

Genprex Inc announced that its collaborators published positive clinical data for the use of Genprex's ONCOPREX Nanoparticle Delivery System for deliv...

January 27, 2022, 1:13 pm

Genprex says preclinical data shows potential for oncoprex nanoparticle delivery system in treating colon cancer

Genprex Inc announced that its collaborators published positive clinical data for the use of Genprex's ONCOPREX Nanoparticle Delivery System for deliv...

January 27, 2022, 1:13 pm

Genprex says preclinical data shows potential for oncoprex nanoparticle delivery system in treating colon cancer

Genprex Inc announced that its collaborators published positive clinical data for the use of Genprex's ONCOPREX Nanoparticle Delivery System for deliv...

January 27, 2022, 1:13 pm

Arbutus biopharma: how will patent win impact stock outlook?

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company with research specialization in chronic hepatitis B virus (HBV). In Decemb...

December 17, 2021, 1:08 pm

Arbutus biopharma: how will patent win impact stock outlook?

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company with research specialization in chronic hepatitis B virus (HBV). In Decemb...

December 17, 2021, 1:08 pm

Arbutus biopharma: how will patent win impact stock outlook?

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company with research specialization in chronic hepatitis B virus (HBV). In Decemb...

December 17, 2021, 1:08 pm


Search within

Pages Search Results: